Safety of intra-arterial chemotherapy with or without osmotic blood–brain barrier disruption for the treatment of patients with brain tumorsKutluay Uluç, Edward A. Neuwelt, Amy Huddleston et al.|Neuro-Oncology Advances|2022Cited by 24
Long-Term Outcomes of Intra-Arterial Chemotherapy for Progressive or Unresectable Pilocytic Astrocytomas: Case StudiesKutluay Uluç, Edward A. Neuwelt, Dominic A. Siler et al.|Neurosurgery|2020Cited by 12
NTOX-09. RECOMMENDED PHASE II DOSE OF INTRA-ARTERIAL MELPHALAN GIVEN WITH INTRA-ARTERIAL CARBOPLATIN, OSMOTIC BLOOD-BRAIN BARRIER DISRUPTION AND DELAYED OTOPROTECTIVE SODIUM THIOSULFATE FOR PATIENTS WITH RECURRENT OR PROGRESSIVE CNS EMBRYONAL OR GERM CELL TUMORSPrakash Ambady, Edward A. Neuwelt, Rongwei Fu et al.|Neuro-Oncology|2017Cited by 0